Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY(R) marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.
Pfizer Inc.: Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY bringing total doses to 300 million for 27 EU member states
All 300 million doses expected to be delivered in 2020 and 2021 Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY
, the companies COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission s decision to exercise its option to purchase an additional 100 million doses under its Advanced Purchase Agreement signed on November 11, 2020. This agreement brings the total number of doses to be delivered to the EU to 300 million.
® bringing total doses to 300 million for 27 EU member states
All 300 million doses expected to be delivered in 2020 and 2021
NEW YORK and MAINZ, GERMANY, December 29, 2020 (GLOBE NEWSWIRE)
BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY
®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s (EC) decision to exercise its option to purchase an additional 100 million doses under its Advanced Purchase Agreement signed on
November 11, 2020. This agreement brings the total number of doses to be delivered to the EU to 300 million.
“We remain committed to moving as quickly and safely as possible to bring this vaccine to more people in Europe, as the deadly virus continues to spread at an alarming rate.”
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
European Union
® bringing total doses to 300 million for 27 EU member states
All 300 million doses expected to be delivered in 2020 and 2021
NEW YORK and MAINZ, GERMANY, December 29, 2020 (GLOBE NEWSWIRE)
BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY
®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s (EC) decision to exercise its option to purchase an additional 100 million doses under its Advanced Purchase Agreement signed on
November 11, 2020. This agreement brings the total number of doses to be delivered to the EU to 300 million.
BioNTech SE: Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY bringing total doses to 300 million for 27 EU member states
All 300 million doses expected to be delivered in 2020 and 2021
NEW YORK and MAINZ, GERMANY, December 29, 2020. This agreement brings the total number of doses to be delivered to the EU to 300 million. We remain committed to moving as quickly and safely as possible to bring this vaccine to more people in Europe, as the deadly virus continues to spread at an alarming rate.
said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. In partnership with the European Commission, member states and healthcare providers, we will be able to reach a total of 150 million Europeans across the continent.